These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 10483993

  • 1. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT, Miki K, Walsh JH, Graham DP, Asaka M, Graham DY.
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [Abstract] [Full Text] [Related]

  • 2. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [Abstract] [Full Text] [Related]

  • 3. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, Ishii H, Hibi T.
    Hepatogastroenterology; 2004 Nov; 51(59):1249-54. PubMed ID: 15362725
    [Abstract] [Full Text] [Related]

  • 4. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K.
    J Gastroenterol; 2003 Nov; 38(4):332-8. PubMed ID: 12743772
    [Abstract] [Full Text] [Related]

  • 5. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N.
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [Abstract] [Full Text] [Related]

  • 6. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

  • 7. Association between serum pepsinogen A and C levels, serum gastrin concentrations and Helicobacter pylori antibodies.
    Kullich W, Pöllmann G, Czerwenka C, Klein G.
    Wien Med Wochenschr; 1999 Jul; 149(7):157-61. PubMed ID: 10413837
    [Abstract] [Full Text] [Related]

  • 8. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q, Ran ZH, Xiao SD.
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [Abstract] [Full Text] [Related]

  • 9. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population.
    Lopes AI, Palha A, Lopes T, Monteiro L, Oleastro M, Fernandes A.
    Scand J Gastroenterol; 2006 May; 41(5):524-31. PubMed ID: 16638693
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M.
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [Abstract] [Full Text] [Related]

  • 11. Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections.
    Nurgalieva ZZ, Opekun AR, Graham DY.
    Helicobacter; 2006 Apr; 11(2):69-74. PubMed ID: 16579835
    [Abstract] [Full Text] [Related]

  • 12. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
    Gisbert JP, Boixeda D, Al-Mostafa A, Vila T, de Rafael L, Alvarez Baleriola I, de Argila CM, Abraira V.
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
    [Abstract] [Full Text] [Related]

  • 13. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, Khosravi F, Massarrat S.
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [Abstract] [Full Text] [Related]

  • 14. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
    Gong Y, Wei W, Yuan Y.
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
    [Abstract] [Full Text] [Related]

  • 15. Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection.
    Daugule I, Ruskule A, Moisejevs G, Rudzite D, Jonaitis L, Janciauskas D, Kiudelis G, Kupcinskas L, Leja M.
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):501-5. PubMed ID: 25822857
    [Abstract] [Full Text] [Related]

  • 16. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, Comparato G, Carloni C, Bertiato G, Battiestel M, Papa N, Aragona G, Cavestro GM, Iori V, Merli R, Bertolini S, Caruana P, Franzé A.
    Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
    [Abstract] [Full Text] [Related]

  • 17. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
    Adamczyk M, Peczek Ł, Rudnicki C, Nawrot B, Stec-Michalska K.
    Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
    [Abstract] [Full Text] [Related]

  • 18. Accuracy of serum pepsinogens I and II, gastrin-17 and anti-helicobacter pylori antibodies in histological diagnoses of atrophic gastritis.
    Irvani S, Hashemi MR, Moghadam KG, Saeidee S, Khavaran K, Najari O, Ranavardi M, Nasiri S, Salmasian H, Rohanizadegan M.
    Minerva Gastroenterol Dietol; 2010 Mar; 56(1):13-7. PubMed ID: 20190719
    [Abstract] [Full Text] [Related]

  • 19. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI, de Aretxabala U X, Santander D R, Sabah T S, Maira S J, Navarro R A, Planzer D M, Gómez L F, Etchart M, Gallegos I, Torrens X, Fasce P G, Reydet I.
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [Abstract] [Full Text] [Related]

  • 20. Changes with aging in gastric biomarkers levels and in biochemical factors associated with Helicobacter pylori infection in asymptomatic Chinese population.
    Shan JH, Bai XJ, Han LL, Yuan Y, Sun XF.
    World J Gastroenterol; 2017 Aug 28; 23(32):5945-5953. PubMed ID: 28932086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.